Gsa Capital Partners LLP Biotechnology

Gsa Capital Partners LLP

$1.11 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RXRX Recursion Pharmaceuticals, Inc.	$996M	$160,000 0.01% of portfolio	30,153	Q1 2025 New
ALT Altimmune, Inc.	$199M	$154,000 0.01% of portfolio	30,778	Q1 2025 Reduced 62.9%
COGT Cogent Biosciences, Inc.	$802M	$151,000 0.01% of portfolio	25,248	Q1 2025 New
RLAY Relay Therapeutics, Inc.	$439M	$137,000 0.01% of portfolio	52,479	Q1 2025 Reduced 59.62%
OVID Ovid Therapeutics Inc.	$33.8M	$137,000 0.01% of portfolio	440,103	Q1 2025 Added 256.12%
VIR Vir Biotechnology, Inc.	$728M	$119,000 0.01% of portfolio	18,399	Q1 2025 New
ADGI Adagio Therapeutics, Inc.	$505M	$117,000 0.01% of portfolio	192,660	Q1 2025 Reduced 58.34%
ROIV Roivant Sciences Ltd.	$8.21B	$117,000 0.01% of portfolio	11,644	Q1 2025 New
SEER Seer, Inc.	$124M	$114,000 0.01% of portfolio	67,380	Q1 2025 Reduced 24.73%
OCUL Ocular Therapeutix, Inc	$876M	$112,000 0.01% of portfolio	15,306	Q1 2025 New
CUE Cue Biopharma, Inc.	$29.4M	$107,000 0.01% of portfolio	117,262	Q1 2025 Reduced 21.72%
MGTX Meira G Tx Holdings PLC	$388M	$103,000 0.01% of portfolio	15,237	Q1 2025 New
ALLK Allakos Inc.	$28M	$102,000 0.01% of portfolio	449,504	Q1 2025 Added 0.75%
WVE Wave Life Sciences Ltd.	$695M	$102,000 0.01% of portfolio	12,643	Q1 2025 New
BCYC Bicycle Therapeutics PLC	$239M	$101,000 0.01% of portfolio	11,952	Q1 2025 New
ARVN Arvinas, Inc.	$413M	$95,000 0.01% of portfolio	13,603	Q1 2025 New
YMAB Y M Abs Therapeutics, Inc.	$189M	$91,000 0.01% of portfolio	20,631	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$441M	$88,000 0.01% of portfolio	15,844	Q1 2025 New
IOVA Iovance Biotherapeutics, Inc.	$369M	$86,000 0.01% of portfolio	25,927	Q1 2025 New
AMLX Amylyx Pharmaceuticals, Inc.	$369M	$82,000 0.01% of portfolio	23,085	Q1 2025 Added 116.98%
INZY Inozyme Pharma, Inc.	$161M	$82,000 0.01% of portfolio	89,651	Q1 2025 New
GALT Galectin Therapeutics Inc	$172M	$81,000 0.01% of portfolio	66,396	Q1 2025 Added 208.33%
BCAB Bio Atla, Inc.	$13.4M	$81,000 0.01% of portfolio	233,156	Q1 2025 Reduced 33.52%
VIGL Vigil Neuroscience, Inc.	$226M	$73,000 0.01% of portfolio	41,128	Q1 2025 New
CCCC C4 Therapeutics, Inc.	$107M	$70,000 0.01% of portfolio	43,941	Q1 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$276M	$70,000 0.01% of portfolio	15,162	Q1 2025 New
TCRX T Scan Therapeutics, Inc.	$35.6M	$58,000 0.01% of portfolio	41,817	Q1 2025 New
RANI Rani Therapeutics Holdings, Inc.	$10.3M	$56,000 0.01% of portfolio	44,633	Q1 2025 New
CRTX Cortexyme, Inc.	$70.5M	$49,000 0.0% of portfolio	36,627	Q1 2025 New
PLRX Pliant Therapeutics, Inc.	$69.1M	$47,000 0.0% of portfolio	34,672	Q1 2025 New
HLVX Hille Vax, Inc.	$68.9M	$34,000 0.0% of portfolio	23,552	Q1 2025 Reduced 65.28%
SLS Sellas Life Sciences Group, Inc.	$38.4M	$25,000 0.0% of portfolio	22,727	Q1 2025 New
ATHA Athira Pharma, Inc.	$14.7M	$25,000 0.0% of portfolio	88,233	Q1 2025 Reduced 70.25%
CMPX Compass Therapeutics, Inc.	$319M	$23,000 0.0% of portfolio	12,187	Q1 2025 New
ANNX Annexon, Inc.	$111M	$22,000 0.0% of portfolio	11,425	Q1 2025 New
PRQR Pro Qr Therapeutics N.V.	$169M	$20,000 0.0% of portfolio	14,683	Q1 2025 New
CRBU Caribou Biosciences, Inc.	$111M	$16,000 0.0% of portfolio	17,605	Q1 2025 New
NAUT Nautilus Biotechnology, Inc.	$91M	$11,000 0.0% of portfolio	12,512	Q1 2025 New
VOR Vor Biopharma Inc.	$90.6M	$9,000 0.0% of portfolio	11,859	Q1 2025 New
CGTX Cognition Therapeutics Inc	$15.7M	$9,000 0.0% of portfolio	22,354	Q1 2025 New
CHRS Coherus Bio Sciences, Inc.	$70M	$8,000 0.0% of portfolio	10,153	Q1 2025 Reduced 91.75%
VERU Veru Inc.	$48.9M	$7,000 0.0% of portfolio	14,978	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.